Common Contracts
6 similar Employment Agreement contracts by Aegerion Pharmaceuticals, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • November 20th, 2007 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of the 1st day of July, 2005, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Gerald Wisler (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 20th, 2007 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of the 1st day of December 2005, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and William J. Sasiela (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 20th, 2007 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of the 1st day of July 2005, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and William H. Lewis (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 10th, 2007 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of the 1st day of July 2005, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and William H. Lewis (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 10th, 2007 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of the 1st day of December 2005, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and William J. Sasiela (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 10th, 2007 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of the 1st day of July, 2005, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Gerald Wisler (the “Executive”).
